A detailed history of O'Shaughnessy Asset Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 458,157 shares of PFE stock, worth $12.3 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
458,157
Previous 333,440 37.4%
Holding current value
$12.3 Million
Previous $9.33 Million 42.13%
% of portfolio
0.12%
Previous 0.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $3.45 Million - $3.91 Million
124,717 Added 37.4%
458,157 $13.3 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $402,770 - $471,972
15,945 Added 5.02%
333,440 $9.33 Million
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $542,395 - $622,843
20,950 Added 7.06%
317,495 $8.81 Million
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $3.11 Million - $4.04 Million
-119,153 Reduced 28.66%
296,545 $8.54 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $2.98 Million - $3.48 Million
-92,861 Reduced 18.26%
415,698 $13.8 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $275,089 - $318,272
-7,616 Reduced 1.48%
508,559 $18.7 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $8.42 Million - $11 Million
-213,702 Reduced 29.28%
516,175 $21.1 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $325,149 - $424,446
7,788 Added 1.08%
729,877 $37.4 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $1.71 Million - $2.08 Million
-38,991 Reduced 5.12%
722,089 $31.6 Million
Q2 2022

Aug 11, 2022

BUY
$46.53 - $55.17 $2.45 Million - $2.91 Million
52,723 Added 7.44%
761,080 $39.9 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $3.2 Million - $3.97 Million
70,020 Added 10.97%
708,357 $36.7 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $936,889 - $1.39 Million
22,674 Added 3.68%
638,337 $37.7 Million
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $10.7 Million - $13.7 Million
271,440 Added 78.86%
615,663 $26.5 Million
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $1.57 Million - $1.78 Million
43,841 Added 14.6%
344,223 $13.5 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $12.8 Million - $14.4 Million
-381,381 Reduced 55.94%
300,382 $10.9 Million
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $13.9 Million - $17.6 Million
-413,890 Reduced 37.78%
681,763 $25.1 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $5.39 Million - $6.32 Million
-169,786 Reduced 13.42%
1,095,653 $40.2 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $338,488 - $410,636
-11,238 Reduced 0.88%
1,265,439 $41.4 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $23 Million - $32.8 Million
849,272 Added 198.7%
1,276,677 $41.7 Million
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $4.91 Million - $5.57 Million
149,047 Added 53.55%
427,405 $16.7 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $1.47 Million - $1.9 Million
45,206 Added 19.39%
278,358 $10 Million
Q2 2019

Aug 07, 2019

SELL
$36.98 - $41.52 $574,595 - $645,137
-15,538 Reduced 6.25%
233,152 $10.1 Million
Q1 2019

May 10, 2019

BUY
$37.5 - $41.2 $207,600 - $228,083
5,536 Added 2.28%
248,690 $0
Q4 2018

Feb 12, 2019

BUY
$38.47 - $43.86 $7.62 Million - $8.68 Million
197,955 Added 437.96%
243,154 $10.6 Million
Q3 2018

Nov 06, 2018

BUY
$34.47 - $41.81 $1.23 Million - $1.5 Million
35,820 Added 381.92%
45,199 $1.99 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $3.47 Million - $3.7 Million
-105,103 Reduced 91.81%
9,379 $338,000
Q1 2018

May 08, 2018

SELL
$31.91 - $37.02 $1.7 Million - $1.98 Million
-53,409 Reduced 31.81%
114,482 $4.06 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $853,418 - $905,506
-25,659 Reduced 13.26%
167,891 $6.08 Million
Q3 2017

Nov 13, 2017

SELL
$31.0 - $34.15 $4.8 Million - $5.29 Million
-154,857 Reduced 44.45%
193,550 $6.91 Million
Q2 2017

Aug 14, 2017

BUY
N/A
348,407
348,407 $11.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.